Rilutek

Links shared publicly online about this topic

Sun Pharma Announces USFDA Tentative Approval For Generic Rilutek(R)

medicalnewstoday.com — “Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted a tentative approval for its Abbreviated New Drug ApplicationView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 30, 2010 at 3:05 pm By:

mnt_musculardys MNT - Muscular Dys Health News

Sun Pharma Announces USFDA Tentative Approval For Generic Rilutek(R) http://mnt.to/3Kyz #musculardystrophy

2 years ago...

USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tablets

news-medical.net — “Sun Pharmaceutical Industries Ltd. announced that USFDA has granted a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Sanofi Aventis's Rilutek® tablets 50 mg.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 29, 2010 at 4:36 am By:

NewsMedical News-Medical.Net Health News

USFDA approves Sun Pharmaceutical's ANDA to market Rilutek tablets: Sun Pharmaceutical Industries Ltd. announced t... http://bit.ly/97Wy06

2 years ago...

Medical News: Lithium Shows No Benefit in ALS - in Neurology, General Neurology from MedPage Today

medpagetoday.com — “Adding lithium to riluzole (Rilutek) in patients with amyotrophic lateral sclerosis (ALS) failed to stop disease progression, researchers said.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on April 5, 2010 at 11:07 pm By:

medical_tweets medical_tweets Health News

Lithium Shows No Benefit in ALS (CME/CE) Adding lithium to riluzole (Rilutek) in patients with amyotrophic lateral sc.. http://bit.ly/aFxNHC

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390